Czechia· CZ-0275508
ROSUVASTATIN VIATRIS
A rosuvastatin product, registered in Czechia by Mylan Ireland Limited, Dublin. The same ATC class is registered in 18 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Rosuvastatin is registered in 18 of 19 countries.
Countries holding a registration under ATC C10AA07 (rosuvastatin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 11 of them publish a price we can compare per daily dose
Rosuvastatin · ATC C10AA07
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of rosuvastatin costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.036 in United States to $0.73 in Switzerland — a ×20 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Rosuvastatin · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.73
- ES Spain$0.39
- IT Italy$0.26
- FR France$0.17
- US United States$0.036 (acquisition cost)
The record
At a glance
SÚKL (Czech Republic)- Manufacturer
- Mylan Ireland Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- C10AA07
- ATC class
- Rosuvastatin
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- August 24, 2026
Packs & prices · 1
1 priced- cz_kod_sukl027550890CZK 345.05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
689 interactions on record for rosuvastatin.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rosuvastatin · interactions on record
689 records
- 29 severe
- 200 moderate
- 20 minor
- 403 info
Most severe, free to view
- ClofibrateC10AB01severe
- GemfibrozilC10AB04severe
- FenofibrateC10AB05severe
- MipomersenC10AX11severe
37 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C10AA07
Rosuvastatin, as other registers publish it.
- CanadaACH-ROSUVASTATINACCORD HEALTHCARE INC
- CanadaACH-ROSUVASTATINACCORD HEALTHCARE INC
- CanadaACH-ROSUVASTATINACCORD HEALTHCARE INC
- CanadaACH-ROSUVASTATINACCORD HEALTHCARE INC
- CanadaAG-ROSUVASTATIN CALCIUMANGITA PHARMA INC.
- CanadaAG-ROSUVASTATIN CALCIUMANGITA PHARMA INC.
- CanadaAG-ROSUVASTATIN CALCIUMANGITA PHARMA INC.
- CanadaAG-ROSUVASTATIN CALCIUMANGITA PHARMA INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e746db2f-eb27-4424-ab7c-e5a4d15bf30a GET /v1/drugs/e746db2f-eb27-4424-ab7c-e5a4d15bf30a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "10MG",
"pack_size": "90",
"substance": "16812",
"cz_kod_sukl": "0275508",
"product_type": "CH",
"registration_state": "B",
"registration_number": "31/106/12-C"
}See everything about rosuvastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.